AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Meczit-PG 750mcg/75mg Tablet

Prescription Icon
Prescription Required

Marketer

Biotrendz Medicaments

Salt Composition

Methylcobalamin (750mcg) + Pregabalin (75mg)

Overview Meczit-PG 750mcg/75mg Tablet

PregaBal 750mcg/75mg tablets are a prescription medication indicated for neuropathic pain management. This medication works by regulating calcium channel function within nerve cells, thereby reducing pain signals. It also offers neuroprotective benefits, promoting nerve fiber health and repair. PregaBal 750mcg/75mg tablets are administered orally, with or without food, ideally at bedtime for consistent plasma levels. Adherence to a regular dosing schedule, as prescribed by your physician, is crucial, given its potential for dependence. Missed doses should be taken upon recollection. Complete the prescribed course, regardless of symptom improvement. Abrupt cessation should be avoided without consulting your doctor. Commonly reported side effects include upper respiratory infection, increased appetite, elevated mood, trembling, vision blurring, dry mouth, vertigo, and somnolence. Avoid tasks demanding concentration until the drug's effects are known. These side effects are usually mild and transient. Weight gain is a possibility; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depressive symptoms, or suicidal ideation to your doctor immediately. Complete disclosure of all other medications is essential, as interactions may compromise efficacy or alter the drug's action. Disclose your pregnancy status, pregnancy plans, or breastfeeding to your doctor before commencing treatment.

Uses of Meczit-PG 750mcg/75mg Tablet

Managing neuropathic pain

Major Benefits of Meczit-PG 750mcg/75mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meczit-PG 750mcg/75mg Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Meczit-PG 750mcg/75mg Tablet:

  • Sleepiness
  • Dizziness
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Increased appetite
  • Blurred vision
  • Constipation
  • Muscle cramp
  • Edema (swelling)
  • Erectile dysfunction
  • Weight gain
  • Balance disorder (loss of balance)
  • Lethargy
  • Vertigo
  • Vomiting
  • Headache
  • Confusion
  • Disorientation
  • Abnormality of voluntary movements

How to use Meczit-PG 750mcg/75mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meczit-PG 750mcg/75mg Tablets can be consumed with or without food, however, consistent daily timing is recommended.

How Meczit-PG 750mcg/75mg Tablet works:

Each Meczit-PG 750mcg/75mg tablet unites methylcobalamin, a vitamin B variant crucial for myelin synthesis (the protective sheath around nerves), and pregabalin, an alpha-2-delta ligand. Methylcobalamin aids nerve fiber protection and repair, while pregabalin's mechanism, involving calcium channel modulation, reduces pain signaling. This synergistic action provides effective relief from neuropathic pain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Meczit-PG 750mcg/75mg tablets and alcohol may result in increased somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Meczit-PG 750mcg/75mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Meczit-PG 750mcg/75mg tablets are likely incompatible. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Meczit-PG 750mcg/75mg tablets might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Meczit-PG 750mcg/75mg tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Meczit-PG 750mcg/75mg tablets in patients with liver conditions is likely safe. Preliminary findings indicate dose modification may be unnecessary, however, physician consultation is recommended.

What if you forget to take Meczit-PG 750mcg/75mg Tablet :

Should you forget to take a Meczit-PG 750mcg/75mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Meczit-PG 750mcg/75mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Central and peripheral nervous system

FAQs on Meczit-PG 750mcg/75mg Tablet

The combined medication Meczit-PG 750mcg/75mg Tablet, containing Pregabalin and Methylcobalamin, offers relief from neuropathic pain. Its mechanism involves modulating the activity of overstimulated or injured nerves within the central nervous system, thus reducing pain perception. Additionally, this formulation promotes the repair of damaged nerves.
Discontinuing Meczit-PG 750mcg/75mg Tablet, even with pain relief, is inadvisable. Follow your physician's prescribed dosage. Abrupt cessation may induce withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual reduction in Meczit-PG 750mcg/75mg Tablet usage is recommended prior to complete discontinuation.
Taking Meczit-PG 750mcg/75mg tablets may increase appetite, potentially leading to weight gain. Weight management is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging meal portions. Limit high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, opt for fruits, vegetables, and low-calorie choices instead of unhealthy snacks. Regular physical activity aids in preventing weight gain. Consistent healthy eating and exercise may preclude weight increase.
Using Meczit-PG 750mcg/75mg Tablets may induce drowsiness or cause sudden sleep onset during routine tasks. This can occur without prior warning signs of drowsiness. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities, especially when initiating treatment, until the medication's effects are understood. Report any such incidents to your physician.
Although infrequent, Meczit-PG 750mcg/75mg Tablet can trigger severe adverse reactions. These may include allergic responses, suicidal ideation, or edema in the extremities (hands, feet, or legs). Discontinue Meczit-PG 750mcg/75mg Tablet and seek immediate medical attention if any such reaction occurs. Allergic reactions can manifest as facial, oral, lip, gum, tongue, or neck swelling; respiratory distress; skin rashes; urticaria (hives); or blistering. Monitor for any abrupt shifts in mood, behavior, cognition, or affect, particularly the emergence of suicidal thoughts.
Patients may experience initial improvements with Meczit-PG 750mcg/75mg tablets within two weeks of starting treatment. Complete therapeutic effects, however, might not be fully realized for two to three months, or even longer in certain individuals.
Should you miss a dose of Meczit-PG 750mcg/75mg Tablet, and your next dose is nearly due, omit the missed dose and continue with your regular schedule. If your next dose is not imminent, take the missed dose immediately upon remembering, then resume your usual dosing pattern. Avoid doubling up on doses to compensate for a missed one, as this could heighten the chance of adverse reactions. For any uncertainty regarding missed doses, seek guidance from your physician.
Increasing the prescribed dosage won't necessarily improve outcomes; in fact, it could significantly raise the risk of adverse reactions and harmful effects. Should your symptoms worsen despite adhering to the recommended dosage, seek immediate medical advice for reassessment.
Avoid consuming alcohol during treatment with Meczit-PG 750mcg/75mg Tablets. Alcohol may worsen the sleepiness this medication can cause.
Routine checkups with your physician are recommended following the commencement of Meczit-PG 750mcg/75mg Tablet therapy. Consult your doctor immediately if your symptoms persist despite adhering to the prescribed dosage, or if adverse reactions interfere with your daily life.
Preserve your medication within its original packaging until needed. Maintain storage in a cool, dry environment. Keep the medication out of the reach and view of children. Proper disposal of any remaining medication is crucial to prevent accidental ingestion by children, pets, or others.
Meczit-PG 750mcg/75mg Tab...
90
MRP 110
18% off